The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 30, 2015
Filed:
Jul. 29, 2014
Applicants:
Heiner Ebel, Biderach an der Riss, DE;
Sara Frattini, Castelleone, IT;
Riccardo Giovannini, Verona, IT;
Christoph Hoenke, Biberach an der Riss, DE;
Thomas Trieselmann, Mettenberg, DE;
Patrick Tielmann, Bad Soden am Taunus, DE;
Inventors:
Heiner Ebel, Biderach an der Riss, DE;
Sara Frattini, Castelleone, IT;
Riccardo Giovannini, Verona, IT;
Christoph Hoenke, Biberach an der Riss, DE;
Thomas Trieselmann, Mettenberg, DE;
Patrick Tielmann, Bad Soden am Taunus, DE;
Assignee:
Boehringer Ingelheim International GmbH, Ingelheim am Rhein, DE;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 498/10 (2006.01); A61K 31/506 (2006.01); C07D 401/06 (2006.01); C07D 401/14 (2006.01); C07D 403/06 (2006.01); C07D 407/14 (2006.01); C07D 413/14 (2006.01); C07D 471/10 (2006.01); A61K 31/5377 (2006.01); A61K 31/55 (2006.01); A61K 31/551 (2006.01); A61K 31/553 (2006.01); C07D 403/14 (2006.01); C07D 405/14 (2006.01); C07D 417/14 (2006.01); C07D 451/02 (2006.01); C07D 471/04 (2006.01); C07D 491/052 (2006.01);
U.S. Cl.
CPC ...
C07D 498/10 (2013.01); A61K 31/506 (2013.01); C07D 401/06 (2013.01); C07D 401/14 (2013.01); C07D 403/06 (2013.01); C07D 407/14 (2013.01); C07D 413/14 (2013.01); C07D 471/10 (2013.01); A61K 31/5377 (2013.01); A61K 31/55 (2013.01); A61K 31/551 (2013.01); A61K 31/553 (2013.01); C07D 403/14 (2013.01); C07D 405/14 (2013.01); C07D 417/14 (2013.01); C07D 451/02 (2013.01); C07D 471/04 (2013.01); C07D 491/052 (2013.01);
Abstract
The present invention relates to a process for the production of novel antagonists for CCR2 (CC chemokine receptor 2) and intermediates thereof.